BIOLASE Has Spent 35 Years Turning Light into Dentistry and Now the Entire Dental Industry Is Catching Up
The global Dental Lasers Market was valued at USD 371.5 Million in 2025 and is projected to reach USD 637.4 Million by 2032, growing at a CAGR of 8.0%, per Maximize Market Research. BIOLASE Inc., the self-declared global leader in dental laser technology and maker of the Waterlase system, is scaling its Epic Pro diode platform and deepening dental support organization partnerships as minimally invasive dentistry transitions from premium option to clinical standard.
There is a dental procedure happening right now in a clinic where no drill is used, no needle is required, and healing time is measured in days rather than weeks. It is performed with a laser. And the company that has built its entire identity around making this the norm in dental practice is BIOLASE Inc.
The Global Dental Lasers Market was valued at USD 371.5 Million in 2025 and is projected to reach USD 637.4 Million by 2032, growing at a CAGR of 8.0%, per Maximize Market Research. BIOLASE, listed on NASDAQ, manufactures the Waterlase all-tissue laser and the Epic Pro diode laser systems, and holds more than 300 patents in dental laser technology, representing one of the most concentrated portfolios in the specialty medical device sector.
The Epic Pro and the All-Tissue Waterlase Platform
In 2024, BIOLASE commercially expanded the Epic Pro, its flagship soft tissue diode laser, with an intelligent temperature monitoring feature that provides real-time feedback during procedures, enabling consistent and predictable outcomes across different tissue types and clinical settings. The device addresses the single most common objection dental practices raise about laser adoption: variability of clinical results. By removing that uncertainty, the Epic Pro is designed to convert skeptical clinicians into committed laser practitioners.
The Waterlase iPlus, BIOLASE’s all-tissue laser system, operates on an erbium wavelength that can cut both soft tissue and hard tissue, including enamel, dentin, and bone, without the heat, vibration, or pressure of conventional rotary instruments. This makes it clinically applicable across endodontic treatment, periodontics, oral surgery, implantology, and conservative dentistry, effectively replacing multiple conventional instruments in a single platform.
DSO Partnerships Are Rewriting the Adoption Curve
The most structurally significant development in BIOLASE’s commercial strategy is its deepening engagement with Dental Support Organizations. In a prior agreement, BIOLASE entered a partnership with Dental Care Alliance (DCA), one of the largest DSOs in the United States, to expand laser adoption and hands-on training programs across its network. DSO partnerships are commercially important because they convert individual practice-level adoption decisions into network-wide procurement programs, accelerating the installation base and generating training-driven engagement that drives recurring consumable revenue.
MMR Insight: The Dental Lasers Market is segmented by product into soft tissue dental lasers, all-tissue dental lasers, dental welding lasers, and dental surgical lasers. Soft tissue dental lasers hold the largest product segment share, driven by their broad applicability in periodontics, cosmetic procedures, and oral surgery. The dental clinics end-user segment dominates, reflecting the high concentration of laser adoption in private practice and group practice environments. Oral surgery is the leading application segment. North America holds the largest regional share, accounting for approximately 45% of the global market, anchored by high dental expenditure and regulatory support. Asia Pacific is the fastest-growing region, driven by rising oral disease prevalence and increasing access to premium dental care.
Final Take
A Dental Lasers Market growing from USD 371.5 Million in 2025 to USD 637.4 Million by 2032 at an 8.0% CAGR is being driven by a simple clinical reality: patients want pain-free, faster-healing dental procedures, and laser dentistry delivers them. BIOLASE has spent 35 years building the technology, the patents, the clinical training infrastructure, and the DSO relationships to be the primary beneficiary of this adoption shift. The dental industry’s slow transition to laser-based care is accelerating. The question is not whether BIOLASE’s market grows. It is how fast the rest of the industry catches up to where BIOLASE already is.
Related Reports
Explore related market intelligence reports from Maximize Market Research: